The Delhi High Court has cancelled the ‘Activepushpa’ trademark, holding it deceptively similar to the earlier registered ‘Hempushpa’ mark. The court ruled that the mark was dishonestly adopted and could confuse consumers of ayurvedic medicines.
The Supreme Court closed the IMA’s case against Patanjali over misleading ads and lifted its stay on the Centre’s deletion of Rule 170. AYUSH medicine ads can now run without prior State licensing approval.
Today, On 3rd July, The Delhi High Court has directed Patanjali to take down advertisements that allegedly disparage Dabur’s Chyawanprash. This interim order came in response to a suit filed by Dabur accusing Patanjali of misleading and negative advertising.
